⏱
👁 651 views
SynAct Pharma - Management presents topline results from Phase 2b ADVANCE study with Q&A
Video Overview & Insights
On June 15 at 10.00 CET, SynAct Pharma will present the topline results from the Phase 2b ADVANCE study with resomelagon in rheumatoid arthritis. Following the presentation, there will be a Q&A session where live viewers have the opportunity to ask questions directly in the chat.